Best Mri Safety Education Podcasts (2024)

1
PsA Podcast: Bimekizumab: Efficacy, safety, and effectiveness in PsA 21:04

5d ago21:04

21:04

Join Professors Peter Nash, Philip Mease, and Laura Coates as they discuss the top publications in the world of PsA. This month, the conversation covered a matching-adjusted indirect comparison (MAIC) to assess the comparative efficacy of bimekizumab and risankizumab in patients with psoriatic arthritis over 52 weeks, and a post hoc analysis invest…

1
Discussing RA: Long-term safety and efficacy of upadacitinib in SELECT trials 19:24

12d ago19:24

19:24

Join Professor Iain McInnes and Professors Hideto Kameda and Rieke Alten for the latest episode on The Immune-Mediated Inflammatory Disease Forum, where they discuss the latest information and data in RA. In this episode, they discuss two papers which investigate the long-term efficacy and safety of upadacitinib in the SELECT trials.…

1
Discussing AxSpA: Incidence of uveitis following bimekizumab treatment 24:11

1M ago24:11

24:11

Join us for the latest axSpA podcast brought to you by the Immune-Mediated Inflammatory Disease Forum! This month, Dr Sofia Ramiro is joined by Professors Hideto Kameda, Atul Deodhar, and Xenofon Baraliakos to discuss a recent study on the incidence of uveitis in patients with axSpA that were treated with bimekizumab.…

1
Author Interview: Professor Laura Andreoli, 2024 44:09

1M ago44:09

44:09

Join Professor Peter Nash from the Griffith University in Brisbane, and Professor Laura Andreoli, a Professor of Rheumatology at the University of Brescia, as they discuss her recent paper ‘The outcomes of children born to mothers with autoimmune rheumatic diseases’, published in The Lancet. Rheumatology on 11th June 2024.…

1
Discussing RA: Neutrophil-to-lymphocyte ratio and treatment response to filgotinib 16:05

2M ago16:05

16:05

Join Professor Iain McInnes and Professors Hideto Kameda and Peter Nash for the latest episode on The Immune-Mediated Inflammatory Disease Forum, where they discuss the latest information and data in RA. In this episode, they discuss a paper that investigated whether the baseline neutrophil-to-lymphocyte ratio had an effect on the treatment respons…

1
Discussing RA: February 2024 10:17

2M ago10:17

10:17

Join Professor Iain McInnes for the latest episode on The Immune-Mediated Inflammatory Disease Forum, where he discusses the latest information and data in rheumatology. In this episode, he discusses two papers that show the long-term safety and efficacy of JAK inhibitors, both of which have a study period of 6.5 years. In our first paper, Roberto …

1
Discussing RA: January 2024 9:43

2M ago9:43

9:43

Join Professor Iain McInnes for the first episode on The Immune-Mediated Inflammatory Disease Forum, where he discusses the latest information and data in rheumatology.In this episode, he discusses two papers that aimed to advise on treatment of rheumatic diseases in a real-world setting. In our first paper, Emma Dures and her colleagues compiled t…

1
Discussing AxSpA: Long-Term Outcomes of Secukinumab & JAKis in Clinical Practice 25:05

2M ago25:05

25:05

Join us for the latest axSpA podcast brought to you by the Immune-mediated Inflammatory Disease forum! This month Dr Sofia Ramiro is joined by Professors Hideto Kameda and Xenofon Baraliakos to discuss the long-term impact of secukinumab treatment on bone-related outcomes and BTMs in r-AxSpA patients over two years. Our faculty then move on to disc…

1
Discussing PsA: Secukinumab & The Effect of Sex on the Long-Term Persistence of Targeted Therapies 30:33

2M ago30:33

30:33

Join Professors Peter Nash, Philip Mease, Frank Behrens, and Laura Coates as they discuss the top publications in the world of PsA. They discuss two highly relevant topics in the field, namely the effect of sex on the long-term persistence of targeted therapies, as well as the impact of secukinumab on synovitis and enthesitis.…

1
Discussing AxSpA: Bimekizumab in AxSpA & Secukinumab Patient Clustering 26:26

2M ago26:26

26:26

Join us for the latest axSpA podcast brought to you by the CSF! This month Dr Sofia Ramiro, consultant rheumatologist and senior researcher at Leiden University Medical Centre and Zuyderland Medical Centre, is joined once again by experts with a wealth of clinical knowledge. Joining her is Hideto Kameda, Professor of Internal Medicine at Toho Unive…

1
Discussing PsA: Guselkumab and analysis of genetic markers 25:46

2M ago25:46

25:46

Join Professors Peter Nash, Philip Mease, and Laura Coates as they discuss the top publications in the world of PsA. This month, the conversation covered the post hoc analysis of PsA patients receiving guselkumab, focusing on disease control across domains and patient characteristics, and a systematic review and meta-analysis on genetic markers and…

1
Discussing PsA: Bimekizumab therapy in PsA 29:49

2M ago29:49

29:49

Join Professors Peter Nash, Philip Mease, and Laura Coates as they discuss the top publications in the world of PsA. This month, they focus on the latest publication by Su, et al. and discuss the latest in bimekizumab therapy in PsA.By The Immune-Mediated Inflammatory Disease Forum

1
Discussing PsA: Clinical Response to Guselkumab & Sequential Lines of b/tsDMARDs 32:10

2M ago32:10

32:10

Join Professors Peter Nash, Philip Mease, and Laura Coates as they discuss the top publications in the world of PsA. They discuss two highly relevant topics in the field, including the clinical response to guselkumab and the research surrounding sequential lines of b/tsDMARDs.By The Immune-Mediated Inflammatory Disease Forum

1
Discussing AxSpA: Risk of Uveitis with Different bDMARDs & PROs following Secukinumab Treatment 32:38

2M ago32:38

32:38

Join us for the latest axSpA podcast brought to you by the Immune-mediated Inflammatory Disease forum! This month Dr Sofia Ramiro is joined by Professors Hideto Kameda, Atul Deodhar and Xenofon Baraliakos to discuss the risk of acute anterior uveitis across different bDMARDs in patients with AS. Our faculty then move on to discuss another publicati…

1
Discussing RA: March 2024 8:39

2M ago8:39

8:39

Join Professor Iain McInnes for the latest episode on The Immune-Mediated Inflammatory Disease Forum, where he discusses the latest information and data in rheumatology. In this episode, he discusses two papers that that add to the knowledge of common treatments relating to RA. In our first paper, Juergen Rech and colleagues present the results of …

1
Discussing PsA: Long-term safety of ixekizumab & bimekizumab treatment in a TNFi-IR population 38:13

2M ago38:13

38:13

Join Professors Peter Nash, Philip Mease, Frank Behrens, and Laura Coates as they discuss the top publications in the world of PsA. They discuss two highly relevant topics in the field, including the long-term safety of ixekizumab as well as bimekizumab treatment in a TNFi-IR population.By The Immune-Mediated Inflammatory Disease Forum

1
Discussing AxSpA: Upadacitinib in nr-axSpA and certolizumab pegol by baseline MRI and CRP status 22:14

2M ago22:14

22:14

Join us for the latest axSpA podcast brought to you by the Immune- ediated Inflammatory Disease Forum! This month, Dr Sofia Ramiro is joined by Professors Hideto Kameda and Xenofon Baraliakos to discuss the results of a Phase 3 trial on upadacitinib in nr-axSpA and the clinical outcomes of certolizumab pegol treatment in nr-axSpA stratified by base…

1
IMID Author Interview: Dr Blanca Hernández-Cruz, 2024 33:50

2M ago33:50

33:50

Join Professor Peter Nash from the Griffith University in Brisbane, and Blanca Hernández-Cruz, a rheumatologist at Virgen Macarena University Hospital in Seville, as they discuss her recent paper ‘Janus kinase inhibitors and tumour necrosis factor inhibitors show a favourable safety profile and similar persistence in rheumatoid arthritis, psoriatic…

1
Discussing AxSpA: Secukinumab retention over time & sacroiliac joint improvements between DMARDs 33:01

2M ago33:01

33:01

Join us for the latest axSpA podcast brought to you by the Immune-mediated Inflammatory Disease forum! This month Dr Sofia Ramiro is joined by Professors Hideto Kameda and Atul Deodhar to discuss the retention rate of secukinumab over two different time periods. Our faculty then move on to discuss another publication, which compares the improvement…

1
Discussing AxSpA: Long-term etanercept response & real-world effectiveness of tofacitinib & adalimumab 29:48

2M ago29:48

29:48

Join us for the latest axSpA podcast brought to you by the Immune-mediated Inflammatory Disease forum! This month, Dr Sofia Ramiro is joined by Professors Hideto Kameda, Atul Deodhar and Xenofon Baraliakos to discuss the long-term etanercept response in patients with radiographic axSpA and the comparison of tofacitinib and adalimumab in a real-worl…

1
Discussing PsA: 2023 EULAR recommendations and improvements in PROs with deucravacitinib 28:33

2M ago28:33

28:33

Join Professors Peter Nash, Philip Mease, and Laura Coates as they discuss the top publications in the world of PsA. This month, they focus on the updated 2023 EULAR recommendations for PsA and the improvement of PROs reported in a Phase 2 trial with deucravacitinib.By The Immune-Mediated Inflammatory Disease Forum

1
Author Interview: Dr Adam Goldman, 2024 21:07

2M ago21:07

21:07

Join Professor Peter Nash from the Griffith University in Brisbane, and Dr Adam Goldman, an epidemiology researcher at The Chaim Sheba Medical Center in Tel-Hashomer, and an epidemiology researcher and lecturer at Tel-Aviv University, as they discuss his recent paper ‘Adverse cardiovascular events in rheumatoid arthritis patients treated with JAK i…

1
2024 ACR Manual: Technologists’ Perspective and How It’s Impacting Workflow 59:02

2M ago59:02

59:02

In this podcast episode, Kellye Mantooth sits down with MRI technologists Kris Seitz, John Reyna, and Randy Parker to explore the implications of the new ACR Manual 2024 on MR safety practices. The discussion delves into scanner utilization, personnel recommendations, and notable changes in the manual, such as the transition from a five gauss bound…

1
Author Interview: Professor Daniel Blockmans, 2024 26:44

2M ago26:44

26:44

Join Professor Peter Nash from the Griffith University in Brisbane, and Professor Daniel Blockmans, from the Department of Internal Medicine at the University Hospitals Leuven, as they discuss his recent paper ‘Efficacy and safety of upadacitinib in patients with giant cell arteritis (SELECT-GCA): A double-blind, randomized controlled Phase 3 trial…

1
The Evolution of MRI Safety 1:11:58

2M ago1:11:58

1:11:58

This conversation with Toby Gilk explores the evolution of MR safety. It begins with a discussion of the early publications on MRI safety, including the 1985 report from the American Association of Physicists in Medicine. The conversation then moves on to the Michael Columbini incident in 2001, which brought attention to the need for better MRI saf…

1
Discussing RA: July 2024 23:23

3M ago23:23

23:23

Join Professor Iain McInnes and guest Professor Maurizio Cutolo for the latest episode on The Immune-Mediated Inflammatory Disease Forum, where they discuss the latest information and data in RA. In this episode, two papers that cover important topics in rheumatology are highlighted: the first paper presents the 5-year efficacy and safety results o…

1
Discussing RA: June 2024 25:59

3M ago25:59

25:59

Join Professors Iain McInnes, Peter Nash, and Maurizio Cutolo for the latest episode on The Immune-Mediated Inflammatory Disease Forum, where they discuss the latest information and data in RA. In this episode they discuss two papers, one that investigated the long-term safety of filgotinib in moderate-to-severe RA, and the other a postmarketing an…

1
Registered Radiologist Asst. w/ Dr. Laurie Coburn 48:59

3M ago48:59

48:59

Episode Link -> RA Program This Episode of Zone 3 podcast between Robert, Laurie Coburn, and Reggie, discussing Laurie's career journey in radiology and the Radiology Practitioner Assistant (RPA) program at Weber State University. Laurie shares her experiences, from discovering her passion for radiology in high school to pursuing various roles such…

1
EULAR 2024 Review Podcast 36:38

3M ago36:38

36:38

Join Dr Sofia Ramiro, Professor Rieke Alten, and Associate Professor Laura Coates as they review their top sessions in RA, PsA, and axSpA from EULAR 2024, providing insight into how these data will shape clinical practice going forward.By The Immune-Mediated Inflammatory Disease Forum

1
EULAR 2024 Highlights: Day 4 2:44

4M ago2:44

2:44

Join Dr Sofia Ramiro as she summarises her top abstracts, posters, and presentations from Day 1 of EULAR 2024 (Saturday, June 15).By The Immune-Mediated Inflammatory Disease Forum

1
EULAR 2024 Highlights: Day 3 4:25

4M ago4:25

4:25

Join Dr Sofia Ramiro as she summarises her top abstracts, posters, and presentations from Day 3 of EULAR 2024 (Friday, June 14).By The Immune-Mediated Inflammatory Disease Forum

1
EULAR 2024 Highlights: Day 2 4:00

4M ago4:00

4:00

Join Dr Sofia Ramiro as she summarises her top abstracts, posters, and presentations from Day 2 of EULAR 2024 (Thursday, June 13).By The Immune-Mediated Inflammatory Disease Forum

1
EULAR 2024 Highlights: Day 1 5:09

4M ago5:09

5:09

Join Dr Sofia Ramiro as she summarises her top abstracts, posters, and presentations from Day 1 of EULAR 2024 (Wednesday, June 12).By The Immune-Mediated Inflammatory Disease Forum

1
EULAR 2024 Preview Podcast 14:00

4M ago14:00

14:00

Join Dr Sofia Ramiro, Professor Rieke Alten, and Associate Professor Laura Coates as they guide you through their top selections in RA, PsA, and axSpA at EULAR 2024, so that you can better plan your time at what will be a busy and exciting congress.By The Immune-Mediated Inflammatory Disease Forum

1
Discussing RA: May 2024 30:08

4M ago30:08

30:08

Join Professor Iain McInnes and guests Professor Janet Pope and Dr Sofia Ramiro for the latest episode on The Immune-Mediated Inflammatory Disease Forum, where he discusses the latest information and data in RA. In this episode, he discusses two papers that investigated the long-term safety of JAK inhibitors from Phase 3 trials. In our first paper,…

1
IMID Author Interview: Dorthe Berthelsen, 2024 23:26

5M ago23:26

23:26

Join Professor Peter Nash from the Griffith University in Brisbane, and Dorthe Berthelsen, a PhD student and physiotherapist at the Parker Institute in Copenhagen and at the University of Southern Denmark, as they discuss her recent paper ‘“I couldn't carry on taking a drug like that”: A qualitative study of patient perspectives on side effects fro…

1
Webinar Highlights Podcast: Evolving Therapeutic Strategies for Psoriatic Diseases 29:42

5M ago29:42

29:42

Webinar Highlights Podcast: Join Professor Iain McInnes and Associate Professor Laura Coates on the Immune-Mediated Inflammatory Disease Forum in their discussion on the recent webinar “Evolving Therapeutic Strategies for Psoriatic Diseases: Not all IL-23s are Created Similar”. Watch them discuss key highlights from the webinar including the burden…

1
IMID Author Interview: Dr Jake Weddell, 2024 21:01

5M ago21:01

21:01

Join Professor Peter Nash from the Griffith University in Brisbane, and Dr Jake Weddell, an academic rheumatology trainee at Leeds Teaching Hospitals NHS Trust, as they discuss his recent paper ‘Real-world experience of IL-17Ai drug survival in a large cohort of axial spondyloarthritis and psoriatic arthritis.’…

1
IMID Author Interview: Professor Frank Verhoeven, 2024 20:36

5M ago20:36

20:36

Join Professor Peter Nash from the Griffith University in Brisbane, and Professor Frank Verhoeven, an Assistant Professor in Rheumatology at the CHU Besancon in France, as they discuss his recent paper ‘Effects of disease‑modifying anti‑rheumatic drugs on sacroiliac MRI score in axial spondyloarthritis: A systematic review and meta‑analysis.’…

1
Discussing RA: April 2024 11:12

5M ago11:12

11:12

Join Professor Iain McInnes for the latest episode on The Immune-Mediated Inflammatory Disease Forum, where he discusses the latest information and data in RA. In this episode, he discusses two papers related to the long-term safety of JAK inhibitors compared to TNF inhibitors. In our first paper, Christina Charles-Schoeman and colleagues assessed …

1
Author Interview: Professor Maria Antonietta D’Agostino, 2024 22:15

6M ago22:15

22:15

Join Professor Peter Nash from the Griffith University in Brisbane, and Maria Antonietta D’Agostino, the Head of the Rheumatology Department at the Catholic University of the Sacred Heart in Rome, as they discuss her recent paper 'Effects of Secukinumab on Synovitis and Enthesitis in Patients with Psoriatic Arthritis: 52-week Clinical and Ultrasoun…

1
Author Interview: Professor Dennis McGonagle, 2024 31:18

6M ago31:18

31:18

Join Professor Peter Nash from the Griffith University in Brisbane, and Professor Dennis McGonagle, a Clinical Professor at the University of Leeds School of Medicine, as they discuss his recent paper ‘Association of the Clinical Components in the Distal Interphalangeal Joint Synovio-entheseal Complex and Subsequent Response to Ixekizumab or Adalim…

1
Defining RF Burns with Kelly Mantooth, MRI Safety Expert 55:17

6M ago55:17

55:17

See Full Video episode -> https://youtu.be/0fJ3uSAQwLg In this episode, Robert and Reggie speak with Kelly Mantooth, an MR Safety expert, about RF burns in MRI. They discuss the definition of RF burns, how they differ from overall heating (SAR), the four types of burns (proximity, looping, resonant, and reflective), statistics on RF burns, causes, …

1
Author Interview: Dr Jürgen Rech, 2024 32:30

6M ago32:30

32:30

Join Professor Peter Nash from the Griffith University in Brisbane, and Dr Jürgen Rech, a Senior Physician at the Friedrich-Alexander University of Erlangen-Nürnberg, as they discuss his recent paper ‘Abatacept Inhibits Inflammation and Onset of Rheumatoid Arthritis in Individuals at High Risk (ARIAA): A Randomised, International, Multicentre, Doub…

1
Pretty Pictures Shortest Time with Rob Cloutier 1:25:31

6M ago1:25:31

1:25:31

See Full Video episode -> https://youtu.be/wFBwmt74wHo?si=s_XFJytnI6dWn2Kr In this episode of Zone 3 Podcast, Reggie and Robert discuss training new MRI technologists. Rob Cloutier, a well-known MRI Educator, discusses his approach to training technologists, focusing on understanding the 'why' behind MRI instead of just memorizing protocols. He tal…

1
Author Interview: Dr Mahta Mortezavi, 2024 20:18

7M ago20:18

20:18

Join Professor Peter Nash from the Griffith University in Brisbane, and Dr Mahta Mortezavi, a Clinical Director for Drug Discovery and Early Development as part of the Anti-infectives Research Unit at Pfizer, as they discuss her recent paper ‘Rheumatoid arthritis disease activity and adverse events in patients receiving tofacitinib or tumour necros…

1
Author Interview: Professor Andrew Cope, Professor Paul Emery and Professor John Issacs 43:10

7M ago43:10

43:10

Join Professor Peter Nash from the Griffith University in Brisbane, as well as Professors Andrew Cope, Professor of Rheumatology and Head of the Centre for Rheumatic Diseases at Kings College London, Professor Paul Emery, Clinical Professor and Director of the Leeds Biomedical Research Centre, and Professor John Isaacs, Professor of clinical immuno…

1
Author Interview: Dr Kehinde Sunmboye, 2024 18:05

8M ago18:05

18:05

Join Professor Peter Nash from the Griffith University in Brisbane, and Dr Kehinde Sunmboye, a consultant rheumatologist at the University Hospitals of Leicester NHS Trust, in this episode of the Author Interview series. Dr Sunmboye discusses his recent paper 'Cardiovascular safety of Janus Kinase inhibitor therapy in a multi-ethnic population' wit…

1
Author Interview: Professor Andrea Rubbert-Roth, 2023 25:17

8M ago25:17

25:17

Join Professor Peter Nash from the Griffith University in Brisbane, and Professor Andrea Rubbert-Roth, a doctor of rheumatology and internal medicine at the Kantonsspital St Gallen in Switzerland, as they discuss her recent paper 'Malignancy in the Upadacitinib Clinical Trials for Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, a…

1
Discussing Rheumatology: December 2023 10:37

10M ago10:37

10:37

Join Professor Iain McInnes in this month's CSF Podcast, where he discusses the latest information and data in rheumatology.In this episode, he discusses two papers that compare the efficacy and safety of JAK inhibitors as RA therapies. In our first paper, Shinya Hayashi and his colleagues carried out a retrospective study to compare the efficacy o…

Podcasts Worth a Listen

Mri Safety Education Podcasts

Podcasts Worth a Listen

Quick Reference Guide